A recent study [81] demonstrated that VDAC1 is overexpressed in PD-like pathology, such as in A53T transgenic mice or cells exposed to MPP+ (1-Methyl-4-phenylpyridine), both of which induce PD-like conditions. This evidence concerns the gene VDAC1 and Parkinson disease.